Max Robotics — Global Service Robot Directory + US Certification

About

Pier Carlo Zorzato is a leading figure in gynecologic oncology, whose research has significantly advanced the safety and efficacy of minimally invasive surgery for endometrial and ovarian cancers. His most impactful work centers on the prevention of vaginal cuff dehiscence (VCD) after laparoscopic and robotic hysterectomy, with his 2021 systematic review and meta-analysis (55 citations) establishing critical benchmarks for complication rates and prevention strategies. Zorzato has also made pivotal contributions to oncologic outcomes, notably through his 2023 meta-analysis (27 citations) examining the controversial use of intrauterine manipulators during hysterectomy for endometrial cancer—a study that directly informs surgical decision-making to minimize recurrence risks. His systematic review on minimally invasive surgery for ovarian cancer recurrence (24 citations) further demonstrates his commitment to optimizing surgical approaches for complex cases. Beyond these landmark reviews, Zorzato has pioneered the evaluation of next-generation robotic platforms, including the Versius® system, and compared single-port versus single-site robotic techniques for early-stage endometrial cancer. With over 100 cumulative citations, his work not only shapes clinical guidelines but also provides a rigorous evidence base for trainees and practitioners navigating the evolving landscape of robotic gynecologic surgery.